Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ascitic fluid alpha 1-antitrypsin.

F G Villamil1, P B Sorroche, H F Aziz

  • 1Hospital Italiano, Internal Medicine (Liver Unit), Buenos Aires, Argentina.

Digestive Diseases and Sciences
|September 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence and Correlates of Smoking among Low-Income Adults Residing in New York City Public Housing Developments-2015.

Journal of urban health : bulletin of the New York Academy of Medicine·2017
Same author

Activation of the alternative pathway of complement during the acute phase of typical haemolytic uraemic syndrome.

Clinical and experimental immunology·2015
Same author

Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2.

Journal of viral hepatitis·2015
Same author

The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm - volume 2.

Journal of viral hepatitis·2015
Same author

Strategies to manage hepatitis C virus (HCV) infection disease burden - volume 2.

Journal of viral hepatitis·2015
Same author

REFINE: a randomized trial comparing cyclosporine A and tacrolimus on fibrosis after liver transplantation for hepatitis C.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014

Ascitic fluid alpha-1-antitrypsin (AF-AAT) is a superior diagnostic marker for ascites compared to total protein and SAAG. This test effectively differentiates between cirrhosis and malignancy, aiding in accurate patient diagnosis.

Area of Science:

  • Gastroenterology and Hepatology
  • Clinical Chemistry
  • Oncology

Background:

  • Ascites diagnosis relies on differentiating between cirrhosis and malignancy.
  • Serum-ascites albumin gradient (SAAG) and ascitic fluid total protein (AF-TP) are commonly used but have limitations.
  • A need exists for more accurate diagnostic markers for ascites.

Purpose of the Study:

  • To evaluate ascitic fluid alpha-1-antitrypsin (AF-AAT) as a diagnostic marker for ascites.
  • To compare the efficacy of AF-AAT with AF-TP and SAAG in differentiating ascites etiology.
  • To assess the utility of AF-AAT in specific patient cohorts, including those with malignancy-induced portal hypertension.

Main Methods:

  • A comparative study involving 82 consecutive patients with ascites.

Related Experiment Videos

  • Measurement of ascitic fluid alpha-1-antitrypsin (AF-AAT), ascitic fluid total protein (AF-TP), and serum-ascites albumin gradient (SAAG).
  • Statistical analysis to determine sensitivity, specificity, and diagnostic efficacy for differentiating cirrhosis from malignant ascites.

    • Main Results:

    • AF-AAT concentrations were significantly elevated in patients with hepatoma, malignant liver disease, and peritoneal neoplasms compared to cirrhotics (P < 0.001).
    • AF-AAT demonstrated high diagnostic performance with 96% sensitivity, 95% specificity, and 96% diagnostic efficacy in distinguishing cirrhosis from malignancy.
    • AF-AAT outperformed AF-TP (87% efficacy) and SAAG (86% efficacy) in this differential diagnosis.

    Conclusions:

    • Ascitic fluid alpha-1-antitrypsin (AF-AAT) is a valuable and superior parameter for the differential diagnosis of ascites.
    • AF-AAT is particularly useful in identifying malignancy-related ascites, even in the presence of portal hypertension.
    • This marker offers improved diagnostic accuracy over traditional methods like AF-TP and SAAG.